Galenica (XSWX:GALE) Change In Receivables : CHF-38 Mil (TTM As of Dec. 2023)

View and export this data going back to 2017. Start your Free Trial

What is Galenica Change In Receivables?

Galenica's change in receivables for the quarter that ended in Dec. 2023 was CHF48 Mil. It means Galenica's Accounts Receivable declined by CHF48 Mil from Jun. 2023 to Dec. 2023 .

Galenica's change in receivables for the fiscal year that ended in Dec. 2023 was CHF-38 Mil. It means Galenica's Accounts Receivable increased by CHF38 Mil from Dec. 2022 to Dec. 2023 .

Galenica's Accounts Receivable for the quarter that ended in Dec. 2023 was CHF486 Mil.

Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed. Galenica's Days Sales Outstanding for the six months ended in Dec. 2023 was 46.81.

In Ben Graham's calculation of liquidation value, Apple Inc's Accounts Receivable are only considered to be worth 75% of book value. Galenica's liquidation value for the six months ended in Dec. 2023 was CHF-857 Mil.

Galenica Change In Receivables Historical Data

The historical data trend for Galenica's Change In Receivables can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Galenica Change In Receivables Chart

Galenica Annual Data

Trend

Dec14

Dec15

Dec16

Dec17

Dec18

Dec19

Dec20

Dec21

Dec22

Dec23

Change In Receivables

Get a 7-Day Free Trial

-29.45

23.72

-57.90

-33.17

-37.82

Galenica Semi-Annual Data
	Dec14	Dec15	Jun16	Dec16	Jun17	Dec17	Jun18	Dec18	Jun19	Dec19	Jun20	Dec20	Jun21	Dec21	Jun22	Dec22	Jun23	Dec23
Change In Receivables	Get a 7-Day Free Trial													67.22	-60.53	27.35	-85.74	47.92

Galenica Change In Receivables Calculation

Change In Accounts Receivable relative to the previous period. It is any increase or decrease in the cash a company is owed by its customers.

Change In Receivables for the trailing twelve months (TTM) ended in Dec. 2023 adds up the semi-annually data reported by the company within the most recent 12 months, which was CHF-38 Mil.

Galenica (XSWX:GALE) Change In Receivables Explanation

1. Accounts Receivable are created when a customer has received a product but has not yet paid for that product. Days Sales Outstanding measures of the average number of days that a company takes to collect revenue after a sale has been made. It is a financial ratio that illustrates how well a company's Accounts Receivable are being managed.

Galenica's Days Sales Outstanding for the quarter that ended in Dec. 2023 is calculated as:

	Days Sales Outstanding
=	Accounts Receivable	/	Revenue	*	Days in Period
=	485.992	/	1894.821	*	91
=	46.81

2. In Ben Graham's calculation of liquidation value, Galenica's accounts receivable are only considered to be worth 75% of book value:

Galenica's liquidation value for the quarter that ended in Dec. 2023 is calculated as:

	Liquidation Value
=	Cash, Cash Equivalents, Marketable Securities	-	Total Liabilities	+	(0.75 * Accounts Receivable)	+	(0.5 * Total Inventories)
=	116.159	-	1515.756	+	0.75 * 485.992	+	0.5 * 357.096
=	-857

Galenica Change In Receivables Related Terms

Thank you for viewing the detailed overview of Galenica's Change In Receivables provided by GuruFocus.com. Please click on the following links to see related term pages.

Galenica (XSWX:GALE) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Distribution » Galenica Ltd. (XSWX:GALE) » Definitions » Change In Receivables

Comparable Companies

Traded in Other Exchanges

GALEz:UK

Address

Untermattweg 8, Bern, CHE, 3027

Website

https://www.galenica.com

Galenica Ltd is an integrated healthcare service provider in Switzerland. The business is primarily operated from two segments Products & Care and Logistics & IT. The Products & Care segment comprises the Retail business area with offerings for patients and end customers and the Professionals business area with offerings for business customers and partners in the healthcare sector. The Logistics & IT segment comprises the two sectors Wholesale and Logistics & IT Services. These provide services for all those involved in the healthcare sector - pharmacies, drugstores, doctors, hospitals and care homes, partners and suppliers.

Galenica (XSWX:GALE) Headlines

No Headlines